Form 4: Beam Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Christine Bellon, Chief Legal Officer of Beam Therapeutics, sold shares of common stock on April 1, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- Christine Bellon, the Chief Legal Officer of Beam Therapeutics, sold 5,674 shares of common stock on April 1, 2025.
- The sale was executed at a weighted average price of $18.3507 per share, with individual transactions ranging from $17.76 to $18.38.
- The shares were sold to cover tax withholding obligations upon the vesting of restricted stock units granted under the company's 2019 Equity Incentive Plan.
- The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 19, 2023.
- Following the transaction, Bellon directly owns 117,294 shares of Beam Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares for tax obligations) and doesn't contain information that would significantly shift sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations are a routine part of equity compensation plans and are not necessarily indicative of the officer's view of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| March 31, 2021 | Date of vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan |
| March 31, 2022 | Date of vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan |
| March 31, 2023 | Date of vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan |
| May 19, 2023 | Date the Reporting Person adopted a Rule 10b5-1 trading plan |
| March 31, 2024 | Date of vesting of certain restricted stock units granted to the Reporting Person under the Beam Therapeutics Inc. 2019 Equity Incentive Plan |
| 04/01/2025 | Date of the transaction (sale of shares) |
| 04/03/2025 | Date of signature on the Form 4 filing |
Keywords
Beam Therapeutics, Christine Bellon, Form 4, Share Sale, Tax Obligations, Rule 10b5-1, Equity Incentive Plan, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.